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Metastatic Melanoma to the Stomach:  
A Rare Cause of Upper Gastrointestinal Bleeding
Ricky Buckshaw, DO,1 Robert Decker, MD,1 Shashin Shah, MD2
1Lehigh Valley Health Network, Department of Internal Medicine, 2Lehigh Valley Health Network, Division of Gastroenterology
INTRODUCTION
Upper gastrointestinal (GI) bleeding is a common diagnosis with annual incidence 
of hospitalization reported as 100 per 100,000 individuals and etiologies are 
many. The most common causes are generally recognized to be esophageal 
varices or peptic ulcer disease. Neoplasm in the stomach is a less common 
cause, and is usually due to primary gastric adenocarcinoma. The gastrointestinal 
tract can also be a site of metastases, however malignant melanoma is a 
relatively rare cause of upper gastrointestinal bleeding, accounting for less than 
3% of all severe cases of bleeding. 
CASE REPORT
The patient is a 76-year-old male with a history of coronary artery disease 
 status post drug-eluting stent, ischemic cardiomyopathy, hyperlipidemia and 
melanoma of the face treated thirty years prior, who presented to the emergency 
department (ED) with hematemesis and melena for 2-3 days prior to admission 
along with progressively worsening dyspnea on exertion and fatigue. The 
 patient had recently started aspirin and clopidogrel following drug eluting stent 
placement. Upon evaluation in the ED, the patient was found to have blood 
pressure 119/78, heart rate 98, respiration rate 18, oxygen saturation 97% on 
2 liters via nasal cannula. A physical exam revealed pallor with poor capillary 
refill. There was no abdominal tenderness. Lab work revealed hemoglobin 5.6, 
white blood cells 13.3, serum creatinine 1.35, troponin 0.26  0.37. In the 
ED, the patient was given two units of packed red blood cells (pRBC) and intra-
venous fluids for volume resuscitation and repeat blood work showed a hemo-
globin of 7.6. The patient was evaluated by gastroenterology who recommended 
esophagogastroduodenoscopy (EGD). The patient was admitted to low level 
monitoring for continued blood transfusion requirement. 
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RESULTS
The patient was initially managed with volume resuscitation 
using crystalloids and blood products. EGD showed large 
gastric ulcer with heaped margins along the greater curvature 
of the stomach with a red the center. An endo clip was placed 
for hemostasis. Biopsies were obtained which later revealed to be 
metastatic malignant melanoma with S100 and MART1 
positivity. Next-generation sequencing was performed 
demonstrating negativity for BRAF, NRAS, and KIT mutations. 
Computed tomography of the head showed an enhancing 
spherical lesion in the right basal ganglia concerning for 
metastatic disease. 
CONCLUSION
Patients with metastatic melanoma to the GI tract have an 
overall poor prognosis with life expectancy as short as four 
months. With the rising incidence of melanoma and its 
subsequent GI metastasis, it is important to recognize 
metastatic disease early and potentially decrease the chance  
of life-threatening complications, which may lead to an early 
death. Only approximately 4% of patients with gastrointestinal 
melanoma are diagnosed prior to death. Prophylactic evaluation 
with endoscopy may be a powerful detection technique in 
patients diagnosed with melanoma and could detect early 
disease and provide treatment options to patients. 
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